iNtRON Biotechnology, Inc. (KOSDAQ:048530)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,070.00
-25.00 (-0.81%)
May 20, 2026, 3:30 PM KST
Market Cap97.05B -26.4%
Revenue (ttm)5.74B -10.6%
Net Income-8.96B
EPS-282.94
Shares Out31.61M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume104,708
Average Volume210,575
Open3,185.00
Previous Close3,095.00
Day's Range2,995.00 - 3,195.00
52-Week Range2,895.00 - 7,010.00
Betan/a
RSI26.49
Earnings DateMar 27, 2026

About iNtRON Biotechnology

iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 048530
Full Company Profile

Financial Performance

In 2025, iNtRON Biotechnology's revenue was 5.74 billion, a decrease of -10.56% compared to the previous year's 6.42 billion. Losses were -8.96 billion, 245.7% more than in 2024.

Financial Statements